Latest news with #PIPAC
Time of India
10-08-2025
- Health
- Time of India
State govt hosp performs PIPAC therapy for abdominal cancer
Raipur: Doctors at the Surgical Oncology Department of state-run Dr Bhimrao Ambedkar Memorial Hospital achieved a significant medical milestone by successfully treating a patient with Peritoneal Carcinomatosis (cancer of the lining of the abdomen) using the Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) technique. Tired of too many ads? go ad free now The 54-year-old female patient successfully completed three sessions of the therapy, marking the first such instance in any govt hospital in central India, claimed the hospital spokesperson. According to Dr Ashutosh Gupta of the Regional Cancer Institute, PIPAC is a new and advanced technique where chemotherapy drugs are delivered as a fine aerosol mist directly into the abdominal cavity under pressure. This method ensures the medicine targets cancer cells directly, minimising the systemic side effects associated with traditional chemotherapy. The procedure is less invasive, requiring only two small incisions, which provides greater comfort to the patient compared to conventional surgery. This procedure is especially beneficial for patients for whom standard chemotherapy or surgery is no longer effective. Research suggests that 60-80% of patients who undergo PIPAC therapy show improvement. Medical experts note that it is rare for patients to complete more than one session of this therapy due to potential complications arising from inadequate patient selection or post-operative care. However, the patient at Pandit Nehru Memorial Hospital completed all three sessions and is now in a stable condition, leading a normal life. Dr Vivek Chaudhary, Dean of Pt Jawaharlal Nehru Medical College, Raipur, said this success is a result of the extensive experience, expertise, and proper use of advanced techniques by the oncological surgery team. He described the department's achievement as a new ray of hope for cancer patients across Chhattisgarh and central India. Tired of too many ads? go ad free now Dr Santosh Sonkar, Superintendent of Dr Bhimrao Ambedkar Hospital, said the successful completion of three PIPAC sessions for advanced abdominal cancer highlights the institution's capabilities. He said it also offers hope to other patients with this type of cancer and establishes the hospital as a leading medical institution in central India. Key facts about the treatment include that PIPAC involves delivering chemotherapy drugs as a fine mist into the peritoneal cavity. This method is used for advanced cancer patients for whom conventional surgery or chemotherapy is not viable. It has been found to be useful in advanced abdominal cancers such as colon, ovarian, and peritoneal metastasis. The technique is an advanced, research-based method available only at a limited number of specialised centres. In India, this procedure was initially started at a few private and advanced govt institutions such as AIIMS Delhi and Tata Memorial Hospital, Mumbai. The successful completion of this procedure by this state govt hospital is a notable achievement, according to the hospital spokesperson.
Time of India
04-06-2025
- General
- Time of India
HCG Manavata Cancer Centre performs first PIPAC procedure for advanced abdominal cancer
Mumbai: HCG Manavata Cancer Centre (HCGMCC) has successfully performed its first PIPAC (Pressurised IntraPeritoneal Aerosol Chemotherapy ) procedure—an advanced, minimally invasive surgical technique used in the management of advanced abdominal cancers. The pioneering procedure was performed on a patient diagnosed with advanced-stage stomach cancer . The surgery was conducted under the expert guidance of Dr. Ninad Katdare from HCG Cancer Centre, Mumbai, in collaboration with Dr. Raj Nagarkar, Managing Director and Chief of Surgical Oncology and Robotic Services at HCGMCC. PIPAC is widely adopted in international oncology centers for treating peritoneal cancers deemed inoperable by conventional standards. This includes cancers originating in the stomach, ovaries, and colon. 'The breakthrough technique allows chemotherapy to be delivered directly into the peritoneal cavity in aerosolized form using laparoscopic access. The pressurized delivery improves drug penetration, allowing for targeted treatment with minimal systemic side effects. It not only maximizes the therapeutic effect of chemotherapy but also enhances patient comfort and recovery,' said Prof. Dr. Raj Nagarkar, Chief of Surgical Oncology and Robotic Services and Managing Director, KIMS Manavata Hospitals, HCG Manavata Cancer Centre and Six Sigma, Nashik. The key advantages of PIPAC include localised, high-concentration drug delivery directly into the peritoneal cavity, which enhances the therapeutic impact on cancerous tissues. It minimises toxicity to healthy organs, thereby reducing systemic side effects commonly associated with traditional chemotherapy. Patients also benefit from faster postoperative recovery due to the minimally invasive nature of the procedure.
